Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 5, 1996, Pages 572-578

  Becker, Karin ^a   Erdbrügger, Wilhelm ^b   Heinroth Hoffmann, Ingrid ^a   Michel, Martin C ^b   Brodde, Otto Erich ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Endothelin receptors; G protein; Inositol phosphates; Kidney; Ontogenesis

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; PERTUSSIS TOXIN; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; KIDNEY CORTEX; MALE; NONHUMAN; ONTOGENY; PROTEIN EXPRESSION; RAT;

EID: 0029990883     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00170830     Document Type: Article

References (40)

1. Bax WA, Bruinnvels AT, van Suylen R-J, Saxena PR, Hoyer D (1993) Endothelin receptors in the human coronary artery, ventricle and atrium. Naunyn-Schmiedeberg's Arch Pharmacol 348: 403-410
2. Bax WA, Saxena PR (1994) The current endothelin receptor classification: time for reconsideration. Trends Pharmacol Sci 15: 379-386
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
4. Brooks DP, DePalma PD, Gellai M, Nambi P, Ohlstein EH, Elliott JD, Gleason JG, Ruffolo RR Jr (1994) Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs. J Pharmacol Exp Ther 271: 769-775
5. Burnette WN (1981) Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112: 195-203
6. 1B-adrenoceptor coupling to inositol phosphate formation in rat kidney. Naunyn-Schmiedeberg's Arch Pharmacol 350: 592-598
7. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW (1994) Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 266: F135-F138
8. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108
9. Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal J-M, Hirth G, Müller M (1994) Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235
10. DeBlasi A, O'Reilly K, Motulsky HJ (1989) Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10: 227-229
11. A receptor antagonist in the rat. J Clin Invest 93: 900-906
12. Guyton AC (1991) Blood pressure control - special role of the kidneys and body fluids. Science 252: 1813-1816
13. Hiley CR, Sang KS (1994) Phosphoinositide stimulation by endothelins in cerebellum of the developing rat. Can J Physiol Pharmacol 72 [Suppl 1]: 108
14. Hocher B, Rohmeiss P, Diekmann F, Zart R, Vogt V, Schiller S, Bauer C, Koppenhagen K, Distler A, Gretz N (1995) Distribution of endothelin receptor subtypes in the rat kidney: renal and hemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 33: 463-472
15. Kon V, Badr KF (1991) Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40: 1-12
16. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T (1989) Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 256: R858-866
17. Krämer BK, Ackermann M, Kohler SM, Riegger GAJ (1994) Role of endothelin in hypertension. Clin Invest 72: 88-93
18. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710
19. Kusumoto K, Kubo K, Kandori H, Kitayoshi T, Sato S, Wakimasu M, Watanabe T, Fujino M (1994) Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci 55: 301-310
20. Leppäluoto J, Ruskoaho H (1992) Endothelin peptides: biological activities, cellular signalling and clinical significance. Ann Med 24: 153-161
21. Lüscher TF, Seo BG, Bühler FR (1993) Potential role of endothelin in hypertension. Hypertension 21: 752-757
22. Masaki T, Vane JR, Vanhoutte PM (1994) International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 46: 137-142
23. 2-, and β-adrenergic receptors and their signaling. Hypertension 22: 169-177
24. Michel MC, Farke W, Erdbrügger W, Philipp T, Brodde O-E (1994) Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension 23: 653-658
25. Mochizuki N, Urasawa K, Sanchez A, Insel PA (1995) Developmental regulation of the α-subunit of Gq/11 as determined by quantitative immunoblot analysis. Biochem Biophys Res Commun 210: 246-252
26. A receptor antagonist. Cardiovasc Drug Rev 12: 48-69
27. Nambi P, Wu H-L, Pullen M, Aiyar N, Bryan H, Elliot J (1992) Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Mol Pharmacol 42: 336-339
28. Rettig R, Schmitt B, Pelzl B, Speck T (1993) The kidney and primary hypertension: contributions from renal transplantation studies in animals and humans. J Hypertens 11: 883-891
29. Roubert P, Gillard-Roubert V, Pourmarin L, Cornet S, Guilmard C, Plas P, Pirotzky E, Chabrier PE, Braquet P (1994) Endothelin receptor subtypes A and B are up-regulated in an experimental model of acute renal failure. Mol Pharmacol 45: 182-188
30. Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46: 325-415
31. Simonson MS (1993) Endothelins: multifunctional renal peptides. Physiol Rev 73: 375-411
32. Sokolovsky M (1992) Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol Ther 54: 129-149
33. Takigawa M, Sakurai T, Kasuya Y, Abe A, Masaki T, Goto K (1995) Molecular identification of guanine-nucleoteide-binding regulatory proteins which couple to endothelin receptors. Eur J Biochem 228: 102-108
34. Ujiie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, Marumo F (1992) Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 90: 1043-1048
35. Urade Y, Fujitani Y, Oda K, Watakabe T, Umemura I, Takai M, Okada T, Sakata K, Karaki H (1992) An endothelin B-receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1 (11-21). FEBS Lett 311: 12-16
36. Van der Ploeg I, Fredholm BB, Carlquist M, Bertorelo A, Aperia A, Celsi G (1991) Localization of several G-protein subunits to the apical and basolateral membranes of cortical tubular cells from the rat kidney. Acta Physiol Scand 142: 83-90
37. A-receptors couple to inositol phosphate formation and inhibition of adenylate cyclase in human right atrium. J Cardiovasc Pharmacol 23: 344-347
38. iα2 enhances phospholipase C signalling. Biochem J 299: 593-596
39. Woodcock EA, Land SL, Andrews RK, Linsenmeyer M, Woodcock DM (1994) A low-affinity, low-molecular-mass endothelin-A receptor in neonatal rat heart. Biochem J 303: 113-119
40. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-115